Century Therapeutics’ Collaboration with Bristol Myers Squibb

Troutman Pepper advised Century Therapeutics on the deal.Century Therapeutics (NASDAQ: IPSC) has announced a research collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY) to…

This content is for members only.
Login to Read More Join Now
Martina Bellini

Author: Martina Bellini

This content is for members only.
Login to Read More Join Now